glp 1 agonist alzheimer Frontiers GLP-1 Agonists Show Promise in

In August 2025, Wegovy was FDA-approved for the treatment of MASH in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) based on results of the ESSENCE trial KNEE OSTEOARTHRITIS (OA) Knee osteoarthritis (OA) is caused and worsened by obesity, as both mechanical stress and obesity-induced inflammation accelerate joint destruction

Effects of rs769217 and rs1001179 polymorphisms of catalase gene on blood catalase, carbohydrate and lipid biomarkers in diabetes mellitus

Embrace the power of vitamin E and unlock the secrets to glowing, healthy skin

Dietary selenium comes from sources like Brazil nuts, seafood, and grains, but soil variations affect availability worldwide

Analysis of free reduced and free oxidised glutathione in wheat flour